Long-term outcomes in patients with acute myocardial infarction and no ischemic changes on electrocardiogram

Karolina Piątek1, ŁukaszPiątek1, Łukasz Zandecki1

  • 1Collegium Medicum, Jan Kochanowski University, Żeromskiego 5, Kielce 25-369, Poland.

Insights

Patients with myocardial infarction (MI) and no ischemic changes (NIC) on ECG have a worse prognosis than previously believed. Their long-term outcomes are similar to those with ST-segment elevation (STE) MI.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Diagnostics

Background:

  • Acute myocardial infarction (MI) diagnosis often relies on electrocardiography (ECG) ischemic changes.
  • A notable patient subset presents with no ischemic changes (NIC) on ECG, exhibiting distinct characteristics and management.
  • The prognostic implications of normal ECGs in MI patients require further clarification, especially with advanced troponin assays.

Purpose of the Study:

  • To compare the clinical outcomes of myocardial infarction (MI) patients presenting with no ischemic changes (NIC) versus those with other ECG patterns.
  • To evaluate the prognostic significance of various ECG findings in acute MI.
  • To clarify the long-term prognosis for MI patients with non-ischemic ECG presentations.

Main Methods:

  • Analysis of 155,073 patients from the Polish Registry of Acute Coronary Syndromes (PL-ACS) between 2012-2018.
  • Classification of MI patients into groups: no ischemic changes (NIC), ST-segment elevation (STE), ST-segment depression (STD), T-wave inversion (TWI), and other ST-T abnormalities (STT).
  • Comparison of in-hospital and 12-month mortality rates across different ECG groups.

Main Results:

  • The no ischemic changes (NIC) group comprised 9.56% of all MI patients.
  • Patients with T-wave inversion (TWI) had a lower in-hospital mortality risk compared to the NIC group.
  • ST-segment elevation (STE), ST-segment depression (STD), and other ST-T abnormalities (STT) groups showed worse short-term outcomes.
  • At 12 months, TWI demonstrated the best prognosis, while STT and STD had the worst.
  • The 12-month mortality rates for STE and NIC groups were similar (9.0% vs. 8.7%, P=0.534), despite STE being an independent predictor.

Conclusions:

  • The long-term prognosis for myocardial infarction (MI) patients with no ischemic changes (NIC) on ECG is less favorable than previously assumed.
  • The outcomes for NIC patients are comparable to those with T-wave inversion (TWI) and ST-segment elevation (STE) MI.
  • These findings highlight the importance of considering non-ischemic ECG findings in MI prognostication.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
67
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
103
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
44
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27